Our Qbank is Coming Soon
Get ready for Praxler’s high-quality Qbanks designed to accelerate your preparation. Try our premium sample questions below.
Detailed Explanation
This patient is presenting with the classic clinical triad of Acute Graft-Versus-Host Disease (GVHD), which occurs within the first 100 days following an allogeneic stem cell transplant. The pathophysiology of GVHD explains every symptom in this vignette:
1. Myeloablative conditioning: High-dose chemotherapy and radiation are used to completely destroy the patient’s native bone marrow. Because the patient has no functional white blood cells, his immune system cannot destroy the incoming donor cells. He is defenseless.
2. Allo-recognition: The donor bone marrow contains fully mature, immunocompetent donor T-lymphocytes. Even though the donor and recipient are “HLA-matched” at major loci, they possess subtle genetic differences in cellular proteins called minor histocompatibility antigens. Because the host cannot fight back, the donor T-cells roam the host’s body and recognize these minor antigens as “foreign.”
3. Targeted Apoptosis (The Symptoms): Once activated, these donor T-cells directly attack the host’s highly proliferative tissues via cell-mediated cytotoxicity.
• The Rash: T-cells attack basal keratinocytes in the epidermis, causing apoptosis that manifests as a maculopapular rash, characteristically starting on the palms and soles.
• The Diarrhea: T-cells attack the crypt cells of the intestinal mucosa. The loss of these cells destroys the gut’s absorptive surface area, causing profuse secretory/watery diarrhea.
• The Labs: T-cells attack the small bile ducts in the liver (cholangiocytes). This biliary destruction impairs bile flow (cholestasis), leading to the buildup of direct (conjugated) bilirubin and alkaline phosphatase (an enzyme lining the bile ducts).
The entire cascade of Acute GVHD is initiated by donor T-cells. They use their T-cell receptor (TCR)—which is structurally stabilized by the CD3 protein complex—to physically bind to the host’s epithelial cells. Selectively depleting these T-cells from the graft prior to transplant removes the “sensors” that trigger this disease, preventing the attack entirely.
This statement describes standard Transplant Rejection (Host-Versus-Graft Disease), such as rejecting a solid kidney transplant. In that scenario, the recipient’s CD4+ Helper T-cells recognize the donor’s tissue as foreign. However, because this patient received myeloablative conditioning, his CD4+ cells were destroyed. The host is physically incapable of mounting an attack against the graft.
Major basic protein (MBP) is found in the granules of eosinophils. Eosinophils destroy large helminthic (worm) parasites and mediate Type I hypersensitivity (allergic) reactions. They do not possess the hypervariable antigen receptors required to recognize subtle differences in human tissue types, and therefore cannot initiate GVHD.
This statement describes the function of macrophages. While macrophages do arrive at the site of tissue damage to clean up cellular debris and release inflammatory cytokines (like TNF-alpha), they are strictly secondary effector cells. Macrophages lack the specific receptors to differentiate between “donor” and “host” tissue; they rely entirely on T-lymphocytes (Choice A) to identify the target.